Age-Related Microbial Differences in Newly Diagnosed Crohn's Disease Reveal the Distinct Enrichment of Oral-Associated Taxa in Pediatric Patients Authors: Yun-Seok Jeong, Kyeong Ok Kim, Yong Eun Park, Yoo Jin Lee, Jeongkuk Seo, Tae-woo Kim, Bo-Hyung Kim, Sung-Vin Yim, Hyun Sik Kim, Jae-Yun Lee, Jin-Woo Bae, Byung-Ho Choe, Ben Kang, Chang Kyun Lee Published: 2026 ABSTRACT Background/AimsCrohn’s disease (CD) presents differently by age of onset, but the microbial distinctions between pediatric and adult CD are currently unclear.MethodsIn this study, the gut microbiota of fecal samples collected from newly diagnosed patients with CD (n=88; pediatric 44, adult 44) and their age- and sex-matched healthy controls (HCs, n=112) was analyzed using 16S rRNA gene amplicon sequencing. Differential abundance analysis was performed using MaAsLin2 to identify age-specific microbial signatures, and enterotypes were classified using Dirichlet multinomial mixture modeling.ResultsBoth pediatric and adult patients with CD exhibited shared dysbiosis characterized by reduced alpha diversity (p<0.001), enrichment of CD-associated pathobionts, such as Enterobacteriaceae and Enterococcaceae, and depletion of short-chain fatty acid-producing taxa within Ruminococcaceae and Lachnospiraceae. Notably, enterotyping revealed that individuals with CD converged toward a shared, pathobiont-dominated enterotype regardless of age, overriding the age-dependent stratification observed in HCs. Despite this shared convergence, differences in age-stratified comparisons were observed. Adult CD patients exhibited enrichment of resident pathobionts such as Ruminococcus gnavus and Clostridium innocuum, whereas pediatric CD patients exhibited unique and pronounced enrichment of Pasteurellaceae, Neisseriaceae, and Gemellaceae (false discovery rate <0.1).ConclusionsIn newly diagnosed patients, CD is characterized by shared dysbiosis and convergence toward a disease-specific enterotype across age groups. However, this was accompanied by distinct microbial features, specifically, the enrichment of taxa previously reported as prevalent in the oral microbiome in children versus resident pathobionts in adults. These findings suggest that age at disease onset is associated with age-stratified differences in microbial profiles in CD. INTRODUCTION Crohn’s disease (CD) is a type of inflammatory bowel disease (IBD), characterized by a complex pathophysiology driven by the interplay of genetic susceptibility, environmental factors, and gut microbiota.1,2 IBD prevalence is continuing to rise globally, including in the United States, Europe, and Asia, representing a growing public health concern.3,4 Although the incidence of IBD is increasing in all age groups, pediatric-onset CD (diagnosed before the age of 18 years) also shows a pronounced rising trend.5,6 Epidemiological studies have documented differences in the clinical characteristics of patients with CD according to age of onset.7,8 Pediatric CD is often associated with a more aggressive and extensive disease, growth impairment, and distinct clinical features, including differences in disease location, disease behavior, and the prevalence of perianal fistulas or abscesses, compared to adult CD.9,10 However, owing to the heterogeneity and complexity of the disease, the factors underlying the distinction between pediatric- and adult-onset CD remain unclear. Although genetic susceptibility is recognized as one of the key contributors to CD pathogenesis, its effect appears to be most pronounced in very early onset CD and becomes less explanatory for disease onset at later ages.11 Accumulating evidence indicates that the gut microbiota plays an essential role in IBD pathogenesis, because dysbiosis and functional alterations in the intestinal microbial community have been consistently linked to chronic inflammation and therapeutic response.12-15 Microbial dysbiosis is characterized by a decrease in short-chain fatty acid-producing bacteria, such as Faecalibacterium prausnitzii, and expansion of pathobionts, including adherent invasive Escherichia coli and Ruminococcus gnavus, whose pro-inflammatory potential has been demonstrated in murine studies.16-18 Previous microbiome studies on pediatric CD have largely focused on the role of gut microbes at disease onset19 and on the therapeutic mechanisms of interventions, such as exclusive enteral nutrition.20 These findings provide important insights into the contribution of microbiota to disease progression and treatment responses in children and adolescents. However, most investigations have focused on cohorts restricted to a single age group (pediatric, adolescent, or adult), and direct comparative analyses of pediatric and adult patients with CD under the same conditions remain scarce. Therefore, it remains unclear whether the profound clinical differences between these two groups are linked to the distinct microbial community structures. Moreover, because the gut microbiome naturally changes with age,21 it is challenging to determine whether the differences observed between pediatric and adult CD represent true disease-specific alterations or merely reflect age-associated variations. To address these gaps, the gut microbiota of newly diagnosed pediatric and adult individuals with CD, together with age- and sex-matched healthy controls (HCs), were investigated across a wide age range. This study aimed to delineate shared versus age-specific microbial signatures of CD and clarify the contribution of gut microbiota to the distinct clinical phenotypes observed in pediatric and adult diseases. MATERIALS AND METHODS 1. Enrollment of participants This study was conducted between December 2018 and June 2025. The study population consisted of four cohorts recruited from Korea. The cohorts included: (1) adult patients with CD from a prospective multicenter IBD study22 (ORIGIN, ClinicalTrials.gov identifier: NCT06124833); (2) pediatric patients with CD from Kyungpook National University Hospital; (3) healthy adults; and (4) healthy pediatric controls from Kyung Hee University Hospital. Participants under 18 years of age were categorized into the pediatric group. In total, 200 individuals were enrolled, comprising newly diagnosed patients with CD (n=88; 44 pediatric, 44 adult) and age- and sex-matched HCs (n=112; 30 pediatric, 82 adult). 2. Crohn's disease Both adult and pediatric patients were newly diagnosed at enrollment. Adult CD met the regional and international diagnostic guidelines,23,24 and pediatric CD (age <18 years at diagnosis) was diagnosed based on the revised Porto criteria.25 Patients with IBD-unclassified status, regardless of age, were excluded. Disease phenotypes were documented using the Montreal classification26 and clinical activity was assessed using the Harvey-Bradshaw Index27 for adults and the Pediatric Crohn’s Disease Activity Index28 for children. The clinical parameters recorded included disease behavior, disease location, upper gastrointestinal (GI) tract involvement, perianal disease (presence of an active fistula or abscess), and history of perianal surgery. Laboratory measurements included white blood cell count, hemoglobin, hematocrit, platelet count, serum albumin, erythrocyte sedimentation rate, fecal calprotectin (FC), C-reactive protein (CRP), and a Simple Endoscopic Score for Crohn’s Disease.29 3. Healthy controls Healthy individuals were systematically recruited from the local community during the same patient enrollment period. The exclusion criteria were as follows: (1) systemic antibiotic exposure within the past 6 months; (2) regular probiotic use for >1 week within the past 6 months; (3) use of medications affecting the GI tract, including analgesics or anti-inflammatory agents, within the past week; and (4) chronic or recent acute GI symptoms, such as diarrhea or abdominal pain. Eligible participants underwent a comprehensive review of their medical and family histories (IBD, diabetes mellitus, hypertension, hyperlipidemia, hepatic or renal disease, neoplasms, and other chronic conditions). For adult controls, additional screening included assessment of hematology, blood biochemistry, urinalysis, and pregnancy testing (in women of childbearing age). Individuals with abnormal results were excluded. To reduce confounding by demographic factors, HCs were selected to match the age and sex distribution of the pediatric and adult CD cohorts. 4. Ethics approval The study was conducted in accordance with the ethical principles of the Declaration of Helsinki and approved by the Institutional Review Boards of the participating hospitals (IRB file numbers: KHUH 2023-08-028-003, KHUH 2023-08-025-003, KHUH 2018-12-004, and KNUCH 2017-09-035). All participants provided written informed consent before enrollment, and consent was obtained from their legal guardians to ensure compliance with the Convention on the Rights of the Child and the laws of the Republic of Korea. 5. Fecal sample collection Participants were provided with a sterile container and instructed to collect approximately 1–2 g of feces immediately after defecation. The samples were delivered to the hospital either directly using cold packs or by a courier under a maintained cold chain. Upon arrival, specimens were stored at −80°C until DNA extraction. 6. 16S rRNA sequencing Pediatric samples were sequenced by targeting the V3–V4 region of the 16S rRNA gene, and adult samples were sequenced for the full-length gene. For 16S rRNA V3–V4 amplicon sequencing, the V3–V4 region was amplified by PCR using primers 341F (5’-CCTACGGGNGGCWGCAG-3’) and 805R (5’-GACTACHVGGGTATCTAATCC-3’). Library preparation was conducted using the Nextera XT Index kit (Illumina, San Diego, CA, USA), according to the manufacturer’s instructions. Libraries were sequenced on a MiSeq platform (Illumina) using a paired-end 2×300 bp reagent kit. For full-length (V1–V9) sequencing, sample processing and library preparation followed the protocol described in the previous paper.22 Briefly, DNA was extracted using a DNeasy PowerSoil Pro Kit (Qiagen, Hilden, Germany). DNA was amplified by PCR using 27F (5’-AGRGTTYGATYMTGGCTCAG-3’) and 1492R (5’-RGYTACCTTGTTACGACTT-3’) with the KAPA HiFi HotStart ReadyMix (Roche, Basel, Switzerland). PCR products were purified using AMPure PB beads (Pacific Biosciences, Menlo Park, CA, USA). A sequencing library was prepared using the SMRTbell Prep Kit 3.0. Sequencing was performed using a PacBio Sequel II platform (Pacific Biosciences). 7. Sequencing data analysis The sequencing quality was assessed using FastQC (v0.12.1). Raw reads were imported into QIIME 2 (v2024.10).30 Primer sequences were removed using Cutadapt (v4.9),31 and raw reads were denoised into amplicon sequence variants using DADA2.32 For full-length 16S rRNA sequences, to avoid sequencing region bias, reads were trimmed to the V3-V4 region using Cutadapt (v4.9) before denoising, and feature tables and representative sequences were then merged for downstream analyses. After quality filtering and DADA2 denoising, samples retained a median sequencing depth of 37,712 reads (interquartile range, 29,838 to 48,876.5), with a minimum depth of 10,163 reads. Taxonomy was assigned using a naïve Bayesian classifier trained on the SILVA database (Release 138.2).33 Non-bacterial sequences assigned to Mitochondria, Chloroplasts, Archaea, or Eukaryotes were filtered out. A phylogenetic tree was constructed using SATé-enabled phylogenetic placement with the q2-fragment-insertion plugin against the SILVA 128 SATé-enabled phylogenetic placement reference database.34 All downstream analyses were conducted using R (v4.4.1, R Core Team 2024; R Foundation for Statistical Computing, Vienna, Austria). 8. Diversity analysis Before diversity analysis, the feature tables were rarefied to 10,163 reads using the R package vegan (v2.6.1). Alpha diversity metrics (observed amplicon sequence variants and Shannon diversity) were calculated using the R package microbiome (v1.28.0). The unweighted UniFrac distance was calculated using the R package rbiom (v2.2.0). Statistical significance of beta diversity was tested using permutational multivariate analysis of variance (PERMANOVA) with the adonis function in the R package vegan (v2.6.10), controlling for covariates, including age and sex. 9. Enterotyping Enterotypes were identified using Dirichlet multinomial mixture models35 based on genus-level abundance tables using the R package Dirichlet Multinomial (v1.48.0). The optimal number of clusters was determined by selecting the model with the lowest Laplace approximation value, which indicated the best goodness-of-fit. 10. Differential abundance analysis Differential abundance analysis was performed using the R package MaAsLin2 (v1.20.0),36 by applying a centered log-ratio transformation and fitting a linear model with age and sex as covariates. Multiple testing corrections were performed using the Benjamini–Hochberg method. 11. Statistical analysis All statistical analyses were conducted in R (v4.4.1) using the rstatix (v0.7.2) and ggpubr (v0.6.0) packages. For demographic characteristics and laboratory measures, categorical variables were summarized as counts and percentages (n, %), and continuous variables were reported as median (interquartile range). Differences in alpha diversity between groups were tested using the Wilcoxon rank-sum test and adjusted for multiple comparisons using the Benjamini–Hochberg method. Pearson correlation analyses were conducted with the R package ggpubr (v0.6.0) to evaluate associations between alpha diversity metrics and clinical parameters. Missing demographic data were handled using available-case analysis, and missing values were left blank in Table 1. RESULTS 1. Clinical characteristics of participants In total, 88 newly diagnosed patients with CD were enrolled, comprising 44 pediatric and 44 adult patients, which formed the basis for a direct comparison between the two age groups. Furthermore, 112 age- and sex-matched HCs (30 pediatric and 82 adult) were included as reference groups (Table 1). Compared to their healthy counterparts, adult patients with CD showed a significantly lower body mass index and serum albumin levels, higher white blood cell and platelet counts, and elevated serum CRP levels. Pediatric patients with CD also demonstrated elevated white blood cell and platelet counts, as well as reduced hemoglobin and serum albumin levels. In the direct comparison of adult and pediatric CD (both n=44), the median age at diagnosis for adults was 31.0 years (interquartile range, 23.0 to 47.5 years) and 13.5 years (interquartile range, 11.0 to 15.0 years) in children (Table 2). Across both groups, patients were predominantly male and most frequently presented with ileocolonic disease (L3) and inflammatory behavior (B1) according to the Montreal classification. The prevalence of a family history of IBD did not differ significantly between adults (11.4%, 5/44) and children (2.3%, 1/44). Upper GI involvement (84.1% vs 13.6%) and perianal disease (63.6% vs 36.4%) were more frequent in pediatric patients than in adult patients with CD. Inflammatory markers (erythrocyte sedimentation rate, CRP, FC) were higher in pediatric CD, indicating a more aggressive phenotype. 2. Shared dysbiosis across pediatric and adult CD In this study, alpha diversity was significantly reduced in both pediatric and adult patients with CD compared to their respective controls, indicating a loss of overall bacterial diversity across age groups (Fig. 1A). Beta diversity based on unweighted UniFrac distances revealed distinct clustering of bacterial communities by group (PERMANOVA, R2=0.093, p=0.001) (Fig. 1B). Pairwise PERMANOVA results for all group comparisons are provided in Supplementary Table 1. Among the covariates, disease status (CD vs healthy) accounted for the largest proportion of variance in bacterial communities (5.2%), underscoring its dominant impact relative to age. Correlation analyses revealed that alpha diversity was negatively correlated with Harvey-Bradshaw Index and serum albumin levels in adults, whereas no significant correlations were observed in pediatric CD (Supplementary Fig. 1). Alpha diversity was not related to disease behavior, location, or the presence of perianal or upper GI involvement in either group (Supplementary Fig. 2A). Collectively, these findings suggest that dysbiosis reflects a shift in the bacterial community structure linked primarily to disease status rather than phenotype-specific variation. Taxonomic profiling further demonstrated alterations in gut microbiota composition in CD (Supplementary Fig. 2B). Compared with HCs, both pediatric and adult patients exhibited a higher relative abundance of Enterobacteriaceae and a lower abundance of Ruminococcaceae, with more pronounced changes in pediatric CD (Supplementary Fig. 2C). Notably, in several pediatric patients, a single CD-associated taxon, such as Enterobacteriaceae, Pseudomonadaceae, or Enterococcaceae, dominated the microbiota, exceeding 90% of the relative abundance (Supplementary Fig. 2B). 3. Shared and age-specific microbial signatures in CD To identify taxa that discriminated between patients with CD and HCs, differential abundance analysis was performed using MaAsLin2 (Supplementary Tables 2-5).36 Irrespective of age, patients with CD showed an enrichment of Enterobacteriaceae, Enterococcaceae, and Fusobacteriaceae (Fig. 1C and D), all of which have been implicated as pathobionts associated with disease progression and severity.19,37 At the genus level, well-known CD-associated taxa, such as Escherichia–Shigella, Enterococcus, Klebsiella, Fusobacterium, and Veillonella, were enriched. In contrast, the families Monoglobaceae, Ruminococcaceae, and Butyricicoccaceae were consistently depleted in patients with CD. Overall, short-chain fatty acid-producing genera, including Agathobacter, Anaerobutyricum, Anaerostipes, Blautia, Coprococcus, Dorea, Fusicatenibacter, Roseburia, and Faecalibacterium, were consistently depleted in patients with CD. Distinct age-specific features emerged beyond the shared dysbiotic features. In adult CD, a selective expansion of resident pathobionts, specifically R. gnavus and Clostridium innocuum, was observed (Fig. 1C). In contrast, pediatric CD was characterized by enrichment of multiple families previously reported as prevalent members of the oral microbiome, including Pasteurellaceae, Porphyromonadaceae, Neisseriaceae, Saccharimonadaceae, and Gemellaceae (Fig. 1D). 4. Age-associated shifts and disease-specific enterotype in gut microbiota To assess whether the gut microbiota of patients with CD could be stratified into distinct subgroups, enterotyping using Dirichlet multinomial mixture modeling was performed based on genus-level abundance data.35 The distributions of enterotypes revealed a fundamental divergence between HCs and patients with CD (chi-square test, n=200; adjusted p=6.78×10−28) (Fig. 2A, Supplementary Tables 6 and 7). Among HCs, samples predominantly fell into Cluster 1 or Cluster 3, with an age-associated increase in Cluster 1. Specifically, 26.7% (8/30) and 66.7% (20/30) of pediatric HCs were assigned to Clusters 1 and 3, respectively, whereas 90.2% (74/82) of adult HCs were assigned to Cluster 1. Taxonomic analysis revealed that these health-associated clusters (1 and 3) were driven by obligate anaerobes and short-chain fatty acid producers such as Bacteroides, Blautia, and Faecalibacterium (Fig. 2B). In contrast, CD onset appears to disrupt this natural age-related stratification. Regardless of age, patients with CD converged toward a shared disease-specific configuration: Cluster 2. This dysbiotic enterotype accounted for most adult (52.3%, 23/44) and pediatric (59.1%, 26/44) CD cases. Cluster 2 was characterized by a collapse of commensal populations and a concomitant dominance of pathobionts, including Escherichia–Shigella, R. gnavus, Veillonella, and Streptococcus, with all associations remaining significant (false discovery rate <0.1). Notably, Dirichlet multinomial mixture cluster assignments showed no significant association with disease phenotypes or clinical laboratory measurements (Supplementary Fig. 3, Supplementary Table 8). DISCUSSION This study comprehensively characterizes the gut microbiota in patients with CD, directly comparing pediatric and adult phenotypes with matched controls. Our data revealed the dual nature of CD-associated dysbiosis: a fundamental convergence toward a pathobiont-dominated enterotype regardless of age, overlaid by age-stratified differences. Specifically, while adult CD is marked by the expansion of resident pathobionts, pediatric CD is uniquely defined by the enrichment of distinct taxa previously reported as prevalent in the oral microbiome. Interestingly, while alpha diversity in adults showed significant inverse correlations with clinical parameters such as Harvey-Bradshaw Index and platelet counts, no such associations were evident in pediatric CD (Supplementary Fig. 1). Furthermore, the endoscopic index (Simple Endoscopic Score for Crohn’s Disease) and surrogate inflammatory markers (FC, erythrocyte sedimentation rate, and CRP) did not correlate with the diversity metrics in either group. However, the relationship between microbial diversity and disease severity remains a subject of ongoing debate. While some adult CD cohorts have shown decreasing alpha diversity with progression from B1 (inflammatory) to B2/B3 (complicated) behavior,38,39 a study on pediatric CD found no meaningful association between diversity metrics and FC.40 In this study, the lack of strong correlations likely reflects the cohort composition; the majority of patients were diagnosed with non-stricturing, non-penetrating (B1, inflammatory) disease. This relatively homogeneous severity profile may have obscured the potential diversity–severity gradients often observed in cohorts with more advanced disease behaviors. Across age groups, CD was characterized by shared dysbiosis, marked by enrichment of well-established CD-associated pathobionts.17 In our results, taxa within Enterobacteriaceae, Enterococcaceae, and Fusobacteriaceae—along with representative genera such as Escherichia–Shigella, Enterococcus, Klebsiella, Fusobacterium, and Veillonella—were enriched irrespective of age, indicating a common disease-associated microbial pattern. However, distinct age-stratified differences in microbial profiles were also observed. In adults, CD was characterized by the selective expansion of resident pathobionts, particularly R. gnavus and C. innocuum. In addition, taxa previously reported as prevalent in the oral microbiome were enriched in adults, predominantly within the families Streptococcaceae and Fusobacteriaceae.41 In contrast, pediatric CD was characterized by enrichment of multiple families previously reported as prevalent in the oral microbiome, including Pasteurellaceae, Porphyromonadaceae, Neisseriaceae, Saccharimonadaceae, and Gemellaceae (Fig. 1D). It should be noted that this enrichment reflects a relative increase in these taxa within fecal samples and does not necessarily indicate ectopic colonization of the gut. While ectopic colonization by oral microbes has been implicated in several diseases, including IBD, colorectal cancer, and rheumatoid arthritis,42 fecal 16S rRNA sequencing alone cannot definitively determine whether these taxa establish viable colonization or reflect relative enrichment resulting from the depletion of resident gut commensals and an overall reduction in microbial load.43 Indeed, the fecal microbial load has been reported to be lower in patients with CD compared with HCs and has been suggested as a major confounding factor in microbiome studies.44,45 Therefore, further studies are required to determine whether these taxa truly originate from the oral cavity and establish viable populations in the gut or whether their apparent increase merely reflects compositional changes. Beyond taxonomic differences, the enterotyping analysis provided ecological insights. HCs displayed age-associated enterotype distributions, with children more frequently assigned to Cluster 3 and adults predominantly assigned to Cluster 1, indicating that enterotypes primarily capture age-related variations in healthy individuals. In contrast, both pediatric and adult CD patients converged toward Cluster 2, a disease-specific enterotype dominated by pathobionts including Escherichia–Shigella, R. gnavus, and Veillonella. This convergence indicates that CD-associated dysbiosis supersedes age-related microbial variations observed in HCs, resulting in a shared pathobiont-enriched configuration across age groups. Notably, the cluster assignment was not associated with specific clinical phenotypes or inflammatory markers. This suggests that the disease-driven community shift toward Cluster 2 represents a fundamental core dysbiosis inherent to the CD state rather than a reflection of clinical heterogeneity. Although these findings provide important insights, several limitations should be acknowledged. First, the sample size was relatively small, and the participants were restricted to a single ethnic group, which may limit the generalizability of these findings. Given that ethnic differences in gut microbial composition have been reported, further validation in larger multi-ethnic cohorts is warranted. Nevertheless, the dysbiotic signatures observed in large Korean cohorts with IBD appear to be largely consistent across ethnic groups,38 suggesting that disease-associated microbial patterns are broadly conserved. Second, as this study was based on multicenter cohort data, the results may have been influenced by differences in the targeted regions of the 16S rRNA gene (conventional V3–V4 versus full-length sequencing). This heterogeneity was unavoidable owing to the transition to an advanced full-length sequencing platform during the study period, which resulted in its application primarily to adult samples collected in the later phase. To minimize batch effects and ensure comparability, all full-length sequences were trimmed to the overlapping V3–V4 region. Importantly, β-diversity analysis performed separately using full-length reads yielded consistent clustering patterns (Supplementary Fig. 4), supporting the overall stability of the observed community structure. Prior evaluations across 16S rRNA variable regions indicated that genus- and higher-level taxonomic profiles remain largely consistent when full-length reads are computationally restricted to commonly targeted regions such as V3–V4,46 and our primary analyses focused on genus- and family-level community patterns rather than species-level resolution; therefore, region-specific or platform-related discrepancies may be less pronounced at these taxonomic ranks. Nevertheless, residual platform-specific effects (e.g., differences in primer sets, PCR amplification efficiency, and library preparation workflows) may persist and could introduce biases in taxonomic recovery and relative abundance estimates, which should be considered when interpreting age-stratified comparisons.47,48 Finally, age-specific microbial patterns require careful interpretation. Given that pediatric CD is often associated with a more aggressive disease course than adult-onset disease,9,10 observed age-stratified differences in microbial profiles may reflect intrinsic biological differences, disease severity, or both. Because clinical severity is closely intertwined with age at diagnosis, isolating age-driven effects from severity-associated microbial alterations remains challenging within a cross-sectional framework. Future studies incorporating severity-matched cohorts or longitudinal sampling across disease progression are essential to disentangle age-related ecological shifts from inflammation-driven microbial changes and to clarify whether the observed patterns represent age-dependent host–microbiome associations. Beyond these technical and demographic limitations, further investigation of mucosa-associated microbiota is warranted to elucidate its role in the age-related heterogeneity of CD. This analysis was based on fecal samples, which may not fully capture the mucosa-associated microbiota. Previous studies have demonstrated that mucosa-associated communities, particularly in the ileum, provide a more accurate representation of microbial dysbiosis in patients with new-onset pediatric CD.19 Moreover, single-cell transcriptome analyses of the terminal ileum and colon in patients with CD revealed location-specific changes in gene expression.49 Therefore, future research integrating microbiome and transcriptome profiling of ileal tissues and diverse GI regions is required to elucidate the role of mucosa-associated microbiota in the age-related heterogeneity of CD. Despite these limitations, this study provides a comprehensive characterization of the gut microbiota across the pediatric–adult spectrum in CD, leveraging well-matched HCs and detailed clinical metadata, thereby enabling a robust evaluation of age- and disease-related effects. In conclusion, to our knowledge, this is the first study to directly compare the gut microbiota of newly diagnosed pediatric and adult patients with CD. We observed a convergence toward shared dysbiosis across age groups, alongside age-stratified differences in microbial profiles, including an enrichment of taxa previously reported as prevalent in the oral microbiome in pediatric CD. Overall, these findings indicate an association between age at disease onset and age-stratified differences in microbial profiles in CD, supporting future investigations of age-specific host–microbiome associations.